Cargando…
Identifying early adopters of COVID-19 vaccines in Latin America
COVID-19 vaccine hesitancy is currently-one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important to identify sources of variation so that policies can be tailored to different population groups. I...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584855/ https://www.ncbi.nlm.nih.gov/pubmed/36328886 http://dx.doi.org/10.1016/j.vaccine.2022.10.033 |
_version_ | 1784813366584279040 |
---|---|
author | Arrieta, Alejandro García-Prado, Ariadna Sarmiento, Juan Pablo Paz Castro, Carmen |
author_facet | Arrieta, Alejandro García-Prado, Ariadna Sarmiento, Juan Pablo Paz Castro, Carmen |
author_sort | Arrieta, Alejandro |
collection | PubMed |
description | COVID-19 vaccine hesitancy is currently-one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important to identify sources of variation so that policies can be tailored to different population groups. In this paper, we analyze the results from a survey designed and implemented in order to identify early adopters and laggers in six big cities located in Argentina, Colombia, Chile, Ecuador, Peru, and Dominican Republic. We find that trust in government and science, accurate knowledge about the value of vaccination and vaccine effects, and perceived risk of getting sick is associated with a higher probability to get vaccinated. We also identify potential laggers such as women and populations with high education but low knowledge about vaccines. We discuss specific strategies to promote vaccination among these populations groups as well as more general strategies designed to gain trust. These findings are specific to the context of Latin America insofar as the underlying factors associated with the choice to be vaccinated vary significantly by location and in relation to individual-level factors. |
format | Online Article Text |
id | pubmed-9584855 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95848552022-10-21 Identifying early adopters of COVID-19 vaccines in Latin America Arrieta, Alejandro García-Prado, Ariadna Sarmiento, Juan Pablo Paz Castro, Carmen Vaccine Article COVID-19 vaccine hesitancy is currently-one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important to identify sources of variation so that policies can be tailored to different population groups. In this paper, we analyze the results from a survey designed and implemented in order to identify early adopters and laggers in six big cities located in Argentina, Colombia, Chile, Ecuador, Peru, and Dominican Republic. We find that trust in government and science, accurate knowledge about the value of vaccination and vaccine effects, and perceived risk of getting sick is associated with a higher probability to get vaccinated. We also identify potential laggers such as women and populations with high education but low knowledge about vaccines. We discuss specific strategies to promote vaccination among these populations groups as well as more general strategies designed to gain trust. These findings are specific to the context of Latin America insofar as the underlying factors associated with the choice to be vaccinated vary significantly by location and in relation to individual-level factors. Elsevier Ltd. 2022-11-22 2022-10-21 /pmc/articles/PMC9584855/ /pubmed/36328886 http://dx.doi.org/10.1016/j.vaccine.2022.10.033 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Arrieta, Alejandro García-Prado, Ariadna Sarmiento, Juan Pablo Paz Castro, Carmen Identifying early adopters of COVID-19 vaccines in Latin America |
title | Identifying early adopters of COVID-19 vaccines in Latin America |
title_full | Identifying early adopters of COVID-19 vaccines in Latin America |
title_fullStr | Identifying early adopters of COVID-19 vaccines in Latin America |
title_full_unstemmed | Identifying early adopters of COVID-19 vaccines in Latin America |
title_short | Identifying early adopters of COVID-19 vaccines in Latin America |
title_sort | identifying early adopters of covid-19 vaccines in latin america |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584855/ https://www.ncbi.nlm.nih.gov/pubmed/36328886 http://dx.doi.org/10.1016/j.vaccine.2022.10.033 |
work_keys_str_mv | AT arrietaalejandro identifyingearlyadoptersofcovid19vaccinesinlatinamerica AT garciapradoariadna identifyingearlyadoptersofcovid19vaccinesinlatinamerica AT sarmientojuanpablo identifyingearlyadoptersofcovid19vaccinesinlatinamerica AT pazcastrocarmen identifyingearlyadoptersofcovid19vaccinesinlatinamerica |